fda warning letters bpc-157 compounding pharmacies letter unapproved new drug In 2023, the FDA deemed 19 peptide drugs too unsafe to be dispensed by pharmacies, which mix components of approved drugs to create bespoke FDA scientists flag concerns with
Description
For people who want maximum simplicity, pre-mixed is easier

This monitoring serves three purposes: confirming that your stack is producing the intended biochemical effects, ensuring safety by tracking organ function and metabolic markers, and providing the data needed to optimize your protocol over time
Harper's BAZAAR

Because large-scale, longitudinal laboratory studies require substantial quantities of the peptide, purchasing individual vials is rarely cost-effective
